veillance System, the Drug Abuse Warning Network, MedWatch, and others.

  1. The Agency for Healthcare Research and Quality (AHRQ) and CDC should be directed to undertake a rigorous economic analysis of the overall direct and indirect health care costs of poisoning and drug overdose.

  2. The Secretary of Health and Human Services should encourage funding by appropriate agencies, such as CDC and the Consumer Product Safety Commission, to ensure the needed flow of information from toxicology researchers in poison control centers on prevention problems and strategies to regulators from toxicology researchers in poison control centers and to encourage the study and development of new regulatory strategies and initiatives to reduce poisonings.

  3. Researchers should be funded through grants from appropriate institutes such as the National Institutes of Health, the National Library of Medicine, AHRQ, and CDC/NCIPC, to study prevention and treatment of poisonings and drug overdose, health service access and delivery, and the cost efficiency and clinical impact of the Poison Prevention and Control System.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement